LEADING THE WAY IN
GENE THERAPIES TARGETING RNA
Locanabio is pioneering a new class of therapeutics by combining two validated approaches for treating diseases—gene therapy and RNA modification. The platform consists of several RNA-targeting systems that are combined with the power of gene therapy delivery to precisely modify dysfunctional RNA and create a novel class of genetic medicines to treat severe diseases.